Table 1.
Characteristics of the participants receiving different eradication regimens.
RBTM group (n = 63) | RATM group (n = 61) | P value | |
---|---|---|---|
Age (years) | 55.0 ± 12.1 | 54.1 ± 12.0 | 0.68 |
Sex | |||
Male | 24 (38.1%) | 33 (54.1%) | 0.07 |
Female | 39 (61.9%) | 28 (45.9%) | |
Smoking | 5 (7.9%) | 7 (11.5%) | 0.51 |
Alcohol drinking | 3 (4.8%) | 2 (3.3%) | 0.68 |
Diagnosis | |||
Gastritis | 29 (46.0%) | 26 (42.6%) | 0.57 |
Gastric ulcer | 7 (11.1%) | 7 (11.5%) | |
Duodenal ulcer | 17 (27.0%) | 23 (37.7%) | |
Peptic ulcer* | 1 (1.6%) | 1 (1.6%) | |
Others | 9 (14.3%) | 4 (6.6%) |
*Peptic ulcer: concurrent gastric ulcer and duodenal ulcer.
RBTM: rabeprazole, bismuth subcitrate, tetracycline, and metronidazole.
RATM: rabeprazole, amoxicillin, tetracycline, and metronidazole.